Ubs Group Ag Neogenomics Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Neogenomics Inc stock. As of the latest transaction made, Ubs Group Ag holds 426,400 shares of NEO stock, worth $4.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

426,400

Previous 138,634 207.57%

Holding current value

$4.73 Million

Previous $2.04 Million 243.79%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.0 - $18.43 $3.74 Million - $5.3 Million	287,766 Added 207.57%	426,400 $7.03 Million
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $852,400 - $1.13 Million	63,612 Added 84.79%	138,634 $2.04 Million
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $44,637 - $54,106	-3,431 Reduced 4.37%	75,022 $1.04 Million
Q1 2024 May 13, 2024	SELL	$14.06 - $16.79 $360,976 - $431,066	-25,674 Reduced 24.66%	78,453 $1.23 Million
Q4 2023 Feb 09, 2024	BUY	$11.67 - $20.73 $824,987 - $1.47 Million	70,693 Added 211.44%	104,127 $1.68 Million
Q3 2023 Nov 09, 2023	SELL	$12.15 - $17.85 $1.03 Million - $1.52 Million	-85,096 Reduced 71.79%	33,434 $411,000
Q2 2023 Aug 11, 2023	BUY	$14.1 - $19.83 $434,985 - $611,755	30,850 Added 35.18%	118,530 $1.9 Million
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $64,429 - $137,861	7,088 Added 8.79%	87,680 $1.53 Million
Q4 2022 Feb 08, 2023	BUY	$6.45 - $12.07 $276,156 - $516,777	42,815 Added 113.34%	80,592 $744,000
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $64,750 - $106,352	8,238 Added 27.89%	37,777 $325,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $158,355 - $313,347	-22,430 Reduced 43.16%	29,539 $241,000
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $382,797 - $1.11 Million	-31,506 Reduced 37.74%	51,969 $632,000
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $21,129 - $33,603	693 Added 0.84%	83,475 $2.85 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $1.79 Million - $2.25 Million	42,913 Added 107.64%	82,782 $3.99 Million
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $1.29 Million - $1.82 Million	-35,214 Reduced 46.9%	39,869 $1.8 Million
Q1 2021 May 12, 2021	SELL	$41.56 - $59.88 $1.71 Million - $2.46 Million	-41,037 Reduced 35.34%	75,083 $3.62 Million
Q4 2020 Feb 11, 2021	BUY	$36.08 - $56.47 $1.34 Million - $2.1 Million	37,210 Added 47.15%	116,120 $6.25 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $519,487 - $632,257	-15,619 Reduced 16.52%	78,910 $2.91 Million
Q2 2020 Jul 31, 2020	SELL	$24.21 - $31.02 $637,255 - $816,508	-26,322 Reduced 21.78%	94,529 $2.93 Million
Q1 2020 May 01, 2020	SELL	$20.5 - $34.53 $546,858 - $921,122	-26,676 Reduced 18.08%	120,851 $3.34 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $1.1 Million - $1.73 Million	58,090 Added 64.95%	147,527 $4.32 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $536,870 - $736,792	28,079 Added 45.76%	89,437 $1.71 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $515,317 - $634,601	26,332 Added 75.18%	61,358 $1.35 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $186,943 - $315,063	-15,399 Reduced 30.54%	35,026 $717,000
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $137,476 - $226,273	12,231 Added 32.02%	50,425 $636,000
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $40,125 - $49,369	3,210 Added 9.18%	38,194 $587,000
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $63,784 - $112,161	7,983 Added 29.57%	34,984 $459,000
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $75,459 - $91,428	-10,437 Reduced 27.88%	27,001 $220,000
Q4 2017 Feb 14, 2018	BUY	$8.02 - $11.18 $19,881 - $27,715	2,479 Added 7.09%	37,438 $331,000
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $11,934 - $14,750	1,310 Added 3.89%	34,959 $389,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,604 Added 59.89%	33,649 $302,000
Q1 2017 Nov 14, 2017	BUY	N/A	21,045	21,045 $167,000

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account